Aileron Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aileron Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2022.
  • Aileron Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $40K, a 73.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $40K -$112K -73.7% Dec 31, 2022 10-K 2024-04-15
Q3 2022 $70K -$107K -60.5% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $98K -$104K -51.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $125K -$103K -45.2% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $152K Dec 31, 2021 10-K 2023-03-20
Q3 2021 $177K -$5.37M -96.8% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $202K -$5.52M -96.5% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $228K -$5.67M -96.1% Mar 31, 2021 10-Q 2021-05-11
Q3 2020 $5.55M -$674K -10.8% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $5.72M -$662K -10.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $5.89M -$650K -9.93% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $6.06M Dec 31, 2019 10-K 2021-03-24
Q3 2019 $6.22M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $6.39M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $6.54M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.